Does granulocyte-macrophage colony-stimulating factor prevent bacterial translocation in rats with surgical trauma and obstructive jaundice?

被引:0
|
作者
Demirbag, Ali E. [1 ]
Turhan, Nesrin [2 ]
Ercis, Serpil [3 ]
Hamaloglu, Erhan [4 ]
机构
[1] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Gastrointestinal Surg, Ankara, Turkey
[2] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Pathol, Ankara, Turkey
[3] Hacettepe Univ, Sch Med, Dept Microbiol & Clin Microbiol, Ankara, Turkey
[4] Hacettepe Univ, Sch Med, Dept Gen Surg, Ankara, Turkey
关键词
GM-CSF; obstructive jaundice; surgical trauma; bacterial translocation; Kupffer cell; GUT BARRIER FUNCTION; INTESTINAL PERMEABILITY; INCREASES BACTERIAL; CONTROLLED-TRIAL; FAILURE; ENDOTOXIN; BLOOD; DYSFUNCTION; ACTIVATION; MICE;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/aims: The incidence of sepsis can be decreased by preventing bacterial translocation, as the first step in enhanced host defense. The aim of this study was to prevent translocation and to increase Kupffer cell incidence by using granulocyte-macrophage colony-stimulating factor in rats with surgical trauma and obstructive jaundice. Methods: Seventy-five Sprague-Dawley rats were randomized into 8 groups. After calibration of laboratory conditions by Group 0, SHAM operations in Groups I, H, HA and common bile duct ligations in Groups III, IV, IVA and V were performed. Granulocyte-macrophage colony-stimulating factor doses were 6 mu g/kg/d in Groups II, IV; 1 mu g/kg/d in HA, IVA postoperatively; and 6 mu g/kg/d in Group V preoperatively, for 7 days. After one week, all rats were reoperated for cecal lymph node, liver and spleen biopsies for culture and histopathology. All culture specimens were identified as positive/negative/contaminated. Survivals were recorded, and after the 21(st) day surviving rats were sacrificed by decapitation. Results: There was no translocation in Group 0 in the three specimens of liver, cecal lymph node and spleen. Group V showed minimal (10%) positivity in only liver, and othergroups ranged between 20-70% in cecal lymph node, liver and spleen tissues, respectively (p<0.05). Kupffer cell incidences were higher in the granulocyte-macrophage colony-stimulating factor given groups than in controls, and lower in common bile duct ligation groups than in SHAM groups (p<0.001). Groups 0 and V showed the best (median 20 days) and Group III the worst (methan 11.7 days) survival (p<0.001). Conclusions: Not only surgical trauma but also obstructive jaundice caused high incidence of translocation, decreased number of Kupffer cells and shortened survival. Translocation ratios were decreased by granulocyte-macrophage colony-stimulating factor in the SHAM and common bile duct ligation groups. Granulocyte-macrophage colony-stimulating factor prevented the decrease in Kupffer cell incidence caused by jaundice and prolonged the survival by preventing translocation at the first step.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [1] Effect of granulocyte-macrophage colony stimulating factor on bacterial translocation after experimental obstructive jaundice
    Ünal, AE
    Çevikel, MH
    Özgün, H
    Tünger, A
    EUROPEAN JOURNAL OF SURGERY, 2001, 167 (05) : 366 - 370
  • [2] Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo
    Aman, MJ
    Stockdreher, K
    Thews, A
    Kienast, K
    Aulitzky, WE
    Farber, L
    Haus, U
    Koci, B
    Huber, C
    Peschel, C
    ANNALS OF HEMATOLOGY, 1996, 73 (05) : 231 - 238
  • [3] Granulocyte-macrophage colony-stimulating factor and the immune system
    Tarr, PE
    MEDICAL ONCOLOGY, 1996, 13 (03): : 133 - 140
  • [4] Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats
    Chung, Joonho
    Kim, Moon Hang
    Yoon, Yong Je
    Kim, Kil Hwan
    Park, So Ra
    Choi, Byung Hyune
    JOURNAL OF NEUROSURGERY-SPINE, 2014, 21 (06) : 966 - 973
  • [6] Deletion Mutants of Human Granulocyte-Macrophage Colony-Stimulating Factor
    L. E. Petrovskaya
    E. A. Kryukova
    A. L. Kayushin
    A. V. Rodina
    E. Yu. Moskaleva
    V. G. Korobko
    Russian Journal of Bioorganic Chemistry, 2002, 28 : 397 - 403
  • [7] Deletion mutants of human granulocyte-macrophage colony-stimulating factor
    Petrovskaya, LE
    Kryukova, EA
    Kayushin, AL
    Rodina, AV
    Moskaleva, EY
    Korobko, VG
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2002, 28 (05) : 397 - 403
  • [8] Emerging paradigms in granulocyte-macrophage colony-stimulating factor signaling
    GomezCambronero, J
    Veatch, C
    LIFE SCIENCES, 1996, 59 (25-26) : 2099 - 2111
  • [9] New clinical applications of granulocyte-macrophage colony-stimulating factor
    Masucci, G
    MEDICAL ONCOLOGY, 1996, 13 (03): : 149 - 154
  • [10] Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma
    Cao, Caineng
    Wang, Le
    Jiang, Feng
    Jin, Qifeng
    Jin, Ting
    Huang, Shuang
    Hu, Qiaoying
    Chen, Yuanyuan
    Piao, Yongfeng
    Hua, Yonghong
    Feng, Xinglai
    Zhou, Yi
    Chen, Xiaozhong
    NEOPLASIA, 2025, 63